NCT07447089 EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
| NCT ID | NCT07447089 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Università Cattolica di Milano |
| Condition | Thyroid Neoplasms |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-12-05 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-12-05 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of the present process-outcome study is to evaluate the feasibility and the effects of an EMDR-IGTP-OTS group intervention on a sample of people with cancer, by using a process-outcome study design, with repeated measures.
Eligibility Criteria
Inclusion Criteria: * cancer diagnosis * PTSD (IES-R \> 32) Exclusion Criteria: * receiving specialized trauma therapy * receiving current psychiatric pharmacological treatment, unless the dosage has been stable for at least 2 months prior to enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07447089 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Thyroid Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07447089 currently recruiting?
Yes, NCT07447089 is actively recruiting participants. Contact the research team at cesarem.cavalera@unicatt.it for enrollment information.
Where is the NCT07447089 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07447089 clinical trial?
NCT07447089 is sponsored by Università Cattolica di Milano. The trial plans to enroll 25 participants.